News
Oak Ridge researchers are converting nuclear waste into components for targeted alpha therapy, a cancer treatment that ...
A radio presenter and Herefordshire teacher was left partially sighted after developing a rare and aggressive cancer.
Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...
Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...
Want a bespoke baby? Check the beauty, brains, or brawn boxes on the embryo order form. Genetic tinkering is no longer science fiction—it’s a market without legal guidelines or societal buy-in. But ...
Discover a study that reveals a targetable CA125+ cell state in rare bladder cancer subtypes using single-cell RNA sequencing.
Drs Kathryn J. Ruddy and Narjust Florez discuss fertility, pregnancy, sexual health, delays in diagnosis, and the financial burden of young-onset cancer survivorship.
Lifezoom, a pioneer of red light therapy in the USA, is excited to expand with the new industry-leading Veyra Series, red ...
Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors ...
Pimple patches have helped make acne ‘acceptable’ and added the fun into functionality, but now the format is expanding to ...
An expert discusses how clinicians and institutions can streamline biomarker-driven therapy decisions by establishing rapid turnaround times for biopsies and pathology results, maintaining in-house ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results